Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Teva
Merck
UBS
Moodys
Cantor Fitzgerald
Harvard Business School
Express Scripts
Colorcon

Generated: July 19, 2018

DrugPatentWatch Database Preview

TELMISARTAN AND AMLODIPINE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Telmisartan And Amlodipine, and when can generic versions of Telmisartan And Amlodipine launch?

Telmisartan And Amlodipine is a drug marketed by Alembic Pharms Ltd, Lupin Ltd, Mylan Pharms Inc, and Torrent Pharms Ltd. and is included in four NDAs.

The generic ingredient in TELMISARTAN AND AMLODIPINE is amlodipine besylate; telmisartan. There are fifty drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the amlodipine besylate; telmisartan profile page.
Summary for TELMISARTAN AND AMLODIPINE
Drug patent expirations by year for TELMISARTAN AND AMLODIPINE

US Patents and Regulatory Information for TELMISARTAN AND AMLODIPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic Pharms Ltd TELMISARTAN AND AMLODIPINE amlodipine besylate; telmisartan TABLET;ORAL 205234-001 Nov 17, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lupin Ltd TELMISARTAN AND AMLODIPINE amlodipine besylate; telmisartan TABLET;ORAL 201586-002 Jan 8, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alembic Pharms Ltd TELMISARTAN AND AMLODIPINE amlodipine besylate; telmisartan TABLET;ORAL 205234-004 Nov 17, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc TELMISARTAN AND AMLODIPINE amlodipine besylate; telmisartan TABLET;ORAL 202516-004 Aug 26, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Julphar
Federal Trade Commission
Daiichi Sankyo
Cipla
Chubb
Healthtrust
Argus Health
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.